Globus Medical, Inc. GMED
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 557.64M | 535.43M | 586.71M | 537.87M | 423.78M |
| Total Depreciation and Amortization | 278.55M | 279.32M | 280.41M | 276.18M | 274.41M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 171.02M | 198.59M | 15.91M | 6.20M | 35.03M |
| Change in Net Operating Assets | -81.29M | -102.95M | -104.51M | -66.80M | -18.02M |
| Cash from Operations | 925.92M | 910.39M | 778.51M | 753.45M | 715.20M |
| Capital Expenditure | -159.37M | -154.80M | -168.19M | -164.68M | -135.59M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -22.42M | -11.08M | -262.12M | -262.21M | -262.21M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -397.29M | -333.14M | -238.76M | 71.88M | 50.12M |
| Cash from Investing | -579.07M | -499.01M | -669.07M | -355.01M | -347.69M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00 | 0.00 | 0.00 | -449.99M | -449.99M |
| Issuance of Common Stock | 115.57M | 110.77M | 104.50M | 89.76M | 96.28M |
| Repurchase of Common Stock | -327.67M | -224.47M | -114.06M | -303.36M | -259.08M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -21.75M | -21.43M | -16.01M | -15.57M | -19.86M |
| Cash from Financing | -233.84M | -135.13M | -25.57M | -679.16M | -632.64M |
| Foreign Exchange rate Adjustments | 2.92M | 2.05M | 15.81M | 22.45M | 14.13M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.92M | 278.30M | 99.68M | -258.28M | -251.00M |